Evli led with nine funds registered in the month, while Goldman Sachs (2), Invesco (2), Schroder (1), Deutsche (1), BNY Mellon (1), Pictet (1), and Lyxor (1) won approval for their mutual fund products.
CCR Monthly Approval Report – February 2018
Deutsche, Nordea, and Acadian each had two of their mutual funds registered, while Investec, Nomura and Lyxor followed, each with one product approved.
CCR Monthly Approval Report – January 2018
Legg Mason, Invesco, Natixis, Lyxor, and Degroof Petercam were the managers registering products in January 2018.
CCR Monthly Approval Report – December 2017
Products from HSBC, Lyxor, Aberdeen and others won approval, as did the first alternatives products from Carlyle Group, Oaktree Capital and Intermediate Capital Group.
CCR Monthly Approval Report – November 2017
iShares, Oddo, Matthews , Lyxor, and Edmond de Rothschild were the fund sponsors gaining approval for new products.
CCR Monthly Approval Report – October 2017
While First Trust led with four ETFs registered in the month, while AllianceBernstein, Axa, LarrainVial and Credicorp Capital also won approval for funds of their own.
CCR Monthly Approval Report – September 2017
Eurizon led with three mutual funds registered in the month, all of them domiciled in Luxembourg, followed by PineBridge and UBAM, each with two funds approved.
CCR Monthly Approval Report – August 2017
Investec and Morgan Stanley had two products each registered, while JP Morgan and Lord Abbett followed completed the list with one fund each.
CCR Monthly Approval Report – July 2017
Only three products were added in the month from three different asset managers: HSBC, Macquarie and Kames Capital.
CCR Monthly Approval Report – June 2017
UBAM led with four mutual funds registered in the month, three of them bond products, followed by Allianz and Investec, each with one fund approved.